Showing results (1141-1150 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 11, 2020
Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring DiseaseSelena Y Lin, Sharon K Huang, Kelly T Huynh, et al.
JCO Precision Oncology|September 11, 2020
Genomic Landscape of Appendiceal NeoplasmsCelina S-P Ang, John Paul Shen, Camille J Hardy-Abeloos, et al.
JCO Precision Oncology|September 11, 2020
Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated MalignanciesVivek Subbiah, Shiraj Sen, Kenneth R Hess, et al.
JCO Precision Oncology|September 11, 2020
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung CancerSebastian Michels, Carina Heydt, Bianca van Veggel, et al.
JCO Precision Oncology|September 11, 2020
Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian CancerJaana Oikkonen, Kaiyang Zhang, Liina Salminen, et al.
JCO Precision Oncology|September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular AssayHatem Soliman, Darl D Flake, Anthony Magliocco, et al.
JCO Precision Oncology|September 14, 2020
Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient OutcomesJerome Jourquin, Stephanie Birkey Reffey, Cheryl Jernigan, et al.
JCO Precision Oncology|September 14, 2020
Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets SuperiorityYing Yuan, J Jack Lee, Susan G Hilsenbeck
JCO Precision Oncology|September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
JCO Precision Oncology|September 14, 2020
Targeting ERBB2 (HER2) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional IndicationsEcaterina E Ileana Dumbrava, Kavitha Balaji, Kanwal Raghav, et al.
Pageof 140